Why the Market is Cheering Valeant’s New CFO
August 22, 2016 at 11:49 AM EDT
Valeant Pharmaceuticals International ( VRX ) has jumped today after the company appointed a new chief financial officer . RBC's Douglas Miehm and Joel Hurren explain why:
